Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

Summary

To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.

Conditions

• Allergic Bronchopulmonary Aspergillosis

Sponsors & Collaborators

• First Affiliated Hospital of Guangxi Medical University

  collaborator OTHER

• Guangzhou Institute of Respiratory Disease

  collaborator OTHER

• Tongji Hospital

  collaborator OTHER

• Nanfang Hospital, Southern Medical University

  collaborator OTHER

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• Qianfoshan Hospital

  collaborator OTHER

• The First Affiliated Hospital of Shanxi Medical University

  collaborator OTHER

• Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

  collaborator OTHER

• West China Hospital

  collaborator OTHER

• Second Affiliated Hospital of Xi'an Jiaotong University

  collaborator OTHER

• Second Affiliated Hospital, School of Medicine, Zhejiang University

  collaborator OTHER

• Xiangya Hospital of Central South University

  collaborator OTHER

• Peking Union Medical College Hospital

  collaborator OTHER

• Ruijin Hospital

  collaborator OTHER

• Peking University Third Hospital

  lead OTHER

Eligibility

Min Age

18 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-10-15

Primary Completion

2025-12-31

Completion

2026-01-31

Countries

• China

Study Locations